Orasis Pharmaceuticals
Israel - HerzliyaPharmaceutical
Focus: Orasis is an Israeli specialty pharmaceutical company focused on eye-drop treatments, particularly for presbyopia and vaginal dryness. The company operates as a small, revenue-generating specialist with a concentrated product portfolio.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Open Jobs
0
About Orasis Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Orasis Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Late-stage
3 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$43K Part DDeclining
LOE Approaching
Sole revenue driver but approaching loss of exclusivity, creating urgent need for pipeline advancement.
Help build intelligence for Orasis Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.